48 week virological response to a triple nucleoside/nucleotide analogue regimen in adults with HIV infection in Africa within the DART trial.

Abstract

HIV-1-infected patients in Uganda and Zimbabwe with high baseline viral load and advanced diseases were treated with zidovudine, lamivudine and tenofovir. The combination of drugs maintained good antiviral efficacy over a period of 48 weeks; the proportion of cases showing signs of resistance increased over time, but no pateints had to be switched to second-line treatment.

Citation

Kaleebu, P. 48 week virological response to a triple nucleoside/nucleotide analogue regimen in adults with HIV infection in Africa within the DART trial. Presented at the 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 24-27 July 2005. (2006)

48 week virological response to a triple nucleoside/nucleotide analogue regimen in adults with HIV infection in Africa within the DART trial.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.